Sleep-disordered breathing and cardiovascular disease

Postgraduate Medical Journal

Volumn 84, Issue 987, 2008, Pages 15-22

  Benjamin, J Amit ^a   Lewis, K E ^a  

^a PRINCE PHILIP HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CENTRAL SLEEP APNEA SYNDROME; CHEYNE STOKES BREATHING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERTENSION; POSITIVE END EXPIRATORY PRESSURE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING;

ADULT; AGED; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RISK FACTORS; SLEEP APNEA SYNDROMES; SLEEP APNEA, OBSTRUCTIVE;

EID: 39049101006     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2007.062836     Document Type: Review

References (85)

1. Spitz A. Das klinische syndrome: Narcolepsy mit Fettsucht und Polyglobulien seinem Beziehungen zum morbus Cushing. Deutsch Arch Klin Med 1937;181:286.
2. Kryger MH. Sleep apnea. From the needles of Dionysius to continuous positive airway pressure. Arch Intern Med 1983;143: 2301-3.
3. Voung T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.
4. Scottish Intercollegiate Guidelines Network. Guideline number 73. June 2003.www.sign.ac.uk (accessed 6 Dec 2007).
5. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89.
6. Krachman S, Criner GJ. Hypoventilation syndromes. Clin Chest Med 1998;19:139-55.
7. Kohnlein T, Welte T, Tan LB, et al. Central sleep apnoea syndrome in patients with chronic heart disease: a critical review of the current literature. Thorax 2002;57:547-54.
8. Wittman V, Rodenstein DO. Health care costs and the sleep apnea syndrome. Sleep Med Rev 2004;8:269-79.
9. Pelletier-Fleury N, Meslier N, Gagnadoux F, et al. Economic arguments for the immediate management of moderate-to-severe obstructive sleep apnoea syndrome. Eur Respir J 2004;23:53-60.
10. Ayas NT, Fitzgerald JM, Fleetham JA, et al. Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med 2006;166:977-84.
11. National Health and Medical Research Council. Effectiveness of nasal continuous positive airway pressure (nCPAP) in obstructive sleep apnoea in adults. Canberra: The Council, 2000.http://www.nhmrc.gov.au (accessed 6 Dec 2007).
12. McNicholas WT, Bonsigore MR. Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 2007;29:156-78.
13. Phillips B. Sleep-disordered breathing and cardiovascular disease. Sleep Med Rev 2005;9:131-40.
14. Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 2004;79:1036-46.
15. Quan SF. Gersh BJ. Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute. Circulation 2004;109:951-7.
16. Shamsuzzaman AS. Gersh BJ. Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 2003;290:1906- 14.
17. Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 1997;157:1746-52.
18. Robinson GV, Stradling JR, Davies RJ. Sleep. 6: Obstructive sleep apnoea/hypopnoea syndrome and hypertension. Thorax 2004;59:1089- 94.
19. Arzt M, Bradley TD. Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 2006;173:1300-8.
20. Yaggi H, Mohsenin V. Obstructive sleep apnoea and stroke. Lancet Neurol 2004;3:333-42.
21. Arzt M, Young T, Finn L, et al. Association of sleep disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med 2005;172:1447-51.
22. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnoea syndrome. Am J Cardiol 1983;52:490-4.
23. Peker Y, Kraiczi H, Hedner J, et al. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999;14:179-84.
24. Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007;49:1625-31.
25. West SD, Nicoll DJ, Stradling JR. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 2006;61:945-50.
26. Bixler EO, Vgontzas AN, Ten Have T, et al. Effects of age on sleep apnea in men. I. Prevalence and severity. Am J Respir Crit Care Med 1998;157:144-8.
27. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001;163:608-13.
28. Redline S, Tishler PV, Hans MG, et al. Racial differences in sleep-disordered breathing in African-Americans and Caucasians. Am J Respir Crit Care Med 1997;155:186-92.
29. Redline S, Tishler PV, Schluchter M, et al. Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med 1999;159:1527-32.
30. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease. Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25.
31. Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med 2002;166:159-65.
32. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.
33. Doherty LS, Kiely JL, Swan V, et al. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005;127:2076-84.
34. Lavie P, Lavie L, Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J 2005;25:514-52.
35. Pepperell JCT, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure following therapeutic and sub-therapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 2002;359:204-10.
36. Rauscher H, Popp W, Zwick H. Systemic hypertension in snorers with and without sleep apnea. Chest 1992;102:367-71.
37. Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 2001;19:2271-7.
38. Lavie P, Herer P and Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000;320:479-82.
39. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA 2000;283:1829-36.
40. Grote L, Ploch T, Heitmann J, et al. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med 1999;160:1875-82.
41. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
42. Hla KM, Young TB, Bidwell T, et al. Sleep apnea and hypertension. A population-based study. Ann Intern Med 1994;120:382-8.
43. Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med 2000;160:2289-95.
44. Kaneko Y, Floras JS, Usui, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003;348:1233-41.
45. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003;107:68-78.
46. Norman D, Loredo JS, Nelesen RA, et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure. Hypertension 2006;47:840-5.
47. Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995;96:1897- 904.
48. Ziegler MG, Mills PJ, Loredo JS, et al. Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 2001;120:887-93.
49. Chobanian AV, Bakris GL, Black HR, and National Heart Lung and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: National High Blood Pressure Education Program Coordinating Committee, The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-72.
50. McMurray JJV, Stewart S. The burden of heart failure. Eur Heart J Suppl 2002;4(Suppl D):D50-8.
51. Javaheri S. Sleep disorders in systolic heart failure: a prospective study of 100 male patients. The final report. Int J Cardiol 2006;106:21-8.
52. Ferrier K, Campbell, Yee B, et al. Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 2005;128:2116-22.
53. Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999;160:1101-6.
54. Wang H, Parker JD, Newton G, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007;49:1632-3.
55. Bradley T D, Floras J. Sleep apnea and heart failure. Part II. Central sleep apnea. Circulation 2003;107:1822.
56. Tkacova R, Hall MJ, Liu PP, et al. Left ventricular volume in patients with heart failure and Cheyne-Stokes respiration during sleep. Am J Respir Crit Care Med 1997;156:1549-555.
57. Spaak J, Egri ZJ, Kubo T, et al. Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension 2005;46:1327-32.
58. Leung RS, Floras JS, Lorenzi-Filho G, et al. Influence of Cheyne-Stokes respiration on cardiovascular oscillations in heart failure. Am J Respir Crit Care Med 2003;167:1534-9.
59. Hall MJ, Ando SI, Floras JS, et al. Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. J Appl Physiol 1998;85:1476-84.
60. Tkacova R, Rankin F, Fitzgerald FS, et al. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation 1998;98:2269-75.
61. Nieminen MS, Böhm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:384-416.
62. Krachman SL, D'Alonzo GE, Berger TJ, et al. Comparison of oxygen therapy with nasal continuous positive airway pressure on Cheyne-Stokes respiration during sleep in congestive heart failure. Chest 1999;116:1550-7.
63. Staniforth AD, Kinnear WJ, Starling R, et al. Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998;19:922-8.
64. Andreas S, Clemens C, Sandholzer H, et al. Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996;27:1486-90.
65. Arzt M, Schulz M, Wensel R, et al. Nocturnal continuous positive airway pressure improves ventilatory efficiency during exercise in patients with chronic heart failure. Chest 2005;127:794-802.
66. Sin DD, Logan AG, Fitzgerald FS, et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000;102:61-6.
67. Arzt M, Schulz M, Wensel R, et al. Nocturnal continuous positive airway pressure improves ventilatory efficiency during exercise in patients with chronic heart failure. Chest 2005;127:794-802.
68. Naughton MT, Liu PP, Bernard DC, et al. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 1995;151:92-7.
69. Bradley TD, Logan AG, Kimoff RJ, et al. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005;353:2025-33.
70. Bayle JY, Grouet A, Gueyffier F, et al. The central sleep apnoea syndrome is frequent in the left ventrcle systolic dysfunction treated with betablockers. Am J Respir Crit Care Med 2007;175:A577.
71. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmias and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983;22:490-4.
72. Becker H, Brandenburg U, Peter JH, et al. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure. Am J Respir Crit Care Med 1995;151:215-18.
73. Tilkian AG, Guilleminault C, Schroeder JS, et al. Sleep induced apnoea syndrome: prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med 1977;63:348-58.
74. Simantirakis N, Schiza SI, Marketou ME, et al. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment. A long-term evaluation using and insertable loop recorder. Eur Heart J 2004;25:1070-6.
75. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med 2006;173:910-16.
76. Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004;110:364-7.
77. Porthan KM, Melin JH, Kupila JT, et al. Prevalence of sleep apnea syndrome in lone atrial fibrillation: a case-control study. Chest 2004;125:879-85.
78. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003;107:2589-94.
79. Peker Y, Kraiczi H, Hedner J, et al. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999;14:179-84.
80. Mooe T, Rabben T, Wiklund U, et al. Sleep-disordered breathing in men with coronary artery disease. Chest 1996;109:659- 63.
81. Mooe T, Rabben T, Wiklund U, et al. Sleep-disordered breathing in women: occurrence and association with coronary artery disease. Am J Med 1996;101:251-6.
82. Gami AS, Howard DE, Olson EJ, et al. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005;352:1206-14.
83. Mooe T, Franklin KA, Holmstrom K, et al. Sleep disordered breathing and coronary artery disease: long-term prognosis. Am J Respir Crit Care Med 2001;164:1910-13.
84. Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J 2006;28:596-602.
85. Hagenah GC, Gueven E, Andreas S. Influence of obstructive sleep apnoea in coronary artery disease: a 10-year follow-up. Respir Med 2006;100:180-2.